ICM
DGX icon

Islay Capital Management’s Quest Diagnostics DGX Stock Holding History

Islay Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-769
Closed -$105K – 287
2022
Q1 		$105K Sell
769
-72
-9% -$10K 0.09% 142
2021
Q4 		$146K Sell
841
-62
-7% -$9.43K 0.11% 115
2021
Q3 		$131K Buy
903
+10
+1% +$1.46K 0.1% 107
2021
Q2 		$118K Sell
893
-81
-8% -$10.6K 0.1% 118
2021
Q1 		$125K Buy
+974
New +$120K 0.1% 136
2020
Q3 		– Sell
-961
Closed -$110K – 287
2020
Q2 		$110K Buy
+961
New +$102K 0.13% 99

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Islay Capital Management's DGX Position: Q2 2022 in Review

Islay Capital Management sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 769 shares — an estimated $105K sold.

Islay Capital Management first reported a position in DGX in Q2 2020 and held it in 6 quarters. The position peaked at $146K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • Islay Capital Management reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Islay Capital Management sold 769 Quest Diagnostics shares in Q2 2022, an estimated $105K.
  • Islay Capital Management first reported a position in Quest Diagnostics in Q2 2020 and held it in 6 quarters.
  • Islay Capital Management's Quest Diagnostics position peaked at $146K in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Islay Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.